13136-53-3

Basic information

• Product Name: (S)-(+)-2-(4-toluenesulfonyloxy)-phenylacetic acid methyl ester
• Synonyms: (S)-(+)-2-(4-toluenesulfonyloxy)-phenylacetic acid methyl ester
• CAS NO: 13136-53-3
• Molecular Weight: 320.366
• Mol File: 13136-53-3.mol

Chemical Properties

• CAS DataBase Reference: (S)-(+)-2-(4-toluenesulfonyloxy)-phenylacetic acid methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-(+)-2-(4-toluenesulfonyloxy)-phenylacetic acid methyl ester(13136-53-3)
• EPA Substance Registry System: (S)-(+)-2-(4-toluenesulfonyloxy)-phenylacetic acid methyl ester(13136-53-3)

Safety Data

• Hazardous Substances Data: 13136-53-3(Hazardous Substances Data)

Upstream product

• 21210-43-5 (S)-Methyl mandelate 
• 98-59-9 p-toluenesulfonyl chloride 

Downstream Products

• 1191446-35-1 (2S,αS)-α-(2-carbamoylpiperidinyl)-α-phenylacetic acid methyl ester 
• 1191446-33-9 (2S,αR)-α-(2-carbamoylpiperidinyl)-α-phenylacetic acid methyl ester 
• 1191446-36-2 (4S,9aS)-4-phenylperhydropyrido[1,2-a]pyrazine-1,3-dione 
• 1191446-34-0 (4R,9aS)-4-phenylperhydropyrido[1,2-a]pyrazine-1,3-dione 
• 1191446-39-5 (2R,αR)-α-(2-carbamoylpiperidinyl)-α-phenylacetic acid methyl ester 
• 2135284-21-6 (R)-1-N-tert-butoxycarbonyl-2-phenylpiperazin-3-one 
• 1240585-54-9 (R)-3-phenyl-2-piperazinone 
• 958852-30-7 (2S,αS)-α-(2-carbamoylpyrrolidin-1-yl)-α-phenylacetic acid methyl ester 
• 958852-31-8 (2S,αR)-α-(2-carbamoylpyrrolidin-1-yl)-α-phenylacetic acid methyl ester 

Relevant articles and documents

A new method for the resolution of amines and its application to 3-amino-1,5-benzodiazepines

A new method for the resolution of racemic amines and its application to 3-amino-1,5-benzodiazepines is reported. The method is based upon the reaction of the amines with a chiral auxiliary, namely the tosyl derivative of (S)-(+)-methyl mandelate, followe

A chemical method for the preparation of novel 1,5-benzodiazepines acting as CCK-B antagonists in high enantiomeric purity

A series of new N-(1,5-benzodiazepin-3-yl)-N'-arylureas, 2, bearing an alkyl substituent at the N5 position of the benzodiazepine nucleus has been studied as potential CCK-B antagonists. The homochiral compounds were obtained by resolving their precursors

Application of piperazine structure containing compound to preparation of LSD1 (Lysine Specific Demethylase 1) inhibitor

The invention discloses application of a piperazine structure containing compound to the preparation of a histone lysine specific demethylase (LSD1) inhibitor. The structural general formula of the compound is as shown in the following descriptions (wherein, A is hydrogen, carbonyl or thiocarbonyl) or a configurational isomer and a pharmaceutical salt thereof, or is as shown in the following descriptions or a pharmaceutical salt thereof. The compound has an obvious inhibition effect on the LSD1, can be prepared into the LSD1 inhibitor, and is used for preventing and treating a disease related to the activity of the histone LSD1.

The synthesis of new diastereomers of (4S,8aS)- and (4R,8aS)-4-phenyl-perhydropyrrole[1,2-a]pyrazine-1,3-dione

The synthesis of new (4S,8aS)- and (4R,8aS)-4-phenyl-perhydropyrrole[1,2-a]pyrazine-1,3-diones in the cyclocondensation reaction of the respective derivatives of l-prolineamide is described. The effect of the amount of NaOEt, temperature, and reaction time on the proportions of diastereomers formed in the cyclocondensation reaction was examined. The structures of the diastereomers were confirmed by GC/MS, HRMS, HPLC, XRD, and 1H and 13C NMR investigations.